GEN Exclusives

More »

GEN News Highlights

More »
Sep 17, 2009

National Jewish Health Accesses InterMune’s Idiopathic Pulmonary Fibrosis DNA Database

  • InterMune will collaborate with National Jewish Health investigators to help further the research of inherited genetic factors that may play a role in idiopathic pulmonary fibrosis (IPF).

    InterMune will provide researchers at National Jewish Health with access to DNA collected from patients who participated in the company’s Phase III trials in IPF for both pirfenidone and actimmune (interferon gamma-1b). The database includes DNA from approximately 1,500 IPF patients.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Sustainability in New Dietary Guidelines

Do you think that sustainability considerations should be incorporated into the new Dietary Guidelines for Americans?

More »